Skip to content

Category: Biotechnology

Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India

By API User

Strategic Partnership to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad’s Genome Valley, Enhancing Global Production and Supply of Isotopically Enriched Chemical Solutions for Pharmaceutical and Electronics Industries TEWKSBURY, MA AND HYDERABAD, INDIA / ACCESS Newswire / October 27, 2025 / Cambridge Isotope Laboratories, Inc. (CIL), and Chemtatva Chiral Solutions, Pvt. Ltd. (CCS), a leading … Continued

ENA Respiratory Attracts AU$34m to Fund Phase II Clinical Studies of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections

By API User

ENA Respiratory, a clinical-stage pharmaceutical company developing antivirals that enhance the body’s natural viral defence mechanisms to minimise the impact of symptomatic viral respiratory infections, announced today that it has raised US$22.4m (AUD$34m) in its Series B financing.   The funding round was supported by existing investors Brandon Capital and Uniseed, with participation from Stoic Venture … Continued

Studies Report New Potential Applications of EBR Systems’ WiSE

By API User

EBR Systems, Inc. (ASX: EBR) (“EBR Systems”, “the Company”), developer of the world’s only left ventricular wireless cardiac pacing device for heart failure, is pleased to report the recent publication of two studies reporting on new, unapproved, clinical applications of the WiSE® System in patients suffering from heart failure. Application 1: WiSE® used to deliver … Continued

4DMedical (ASX:4DX) CT:VQ(TM) commercial rollout commences at Stanford and AstraZeneca expands partnership across Brazil

By API User

Highlights • Less than two months after FDA clearance, Stanford University becomes the first U.S. Academic Medical Centre (AMC) to adopt CT:VQ™ under a commercial contract • 4DMedical and AstraZeneca expand the Lung Health Screening Program in Brazil to five additional hospitals, covering 38,000 CT scans annually Melbourne, Australia, 22 October 2025: 4DMedical Limited (ASX: 4DX, … Continued

BlinkLab Limited (ASX:BB1) Confirms Strong Pilot Study Results and FDA Alignment for Autism Diagnostic Device

By API User

22 October 2025 – Sydney, Australia | BlinkLab Limited (ASX:BB1), an ASX-listed digital healthcare company developing AI-powered diagnostic tools, today announced the successful completion and unblinding of its U.S. Pilot Study evaluating the performance of its smartphone-based autism diagnostic test, BlinkLab Dx 1. The pilot results demonstrate strong diagnostic accuracy, while a recent meeting with … Continued

Nexsen Limited (ASX:NXN) Launches Clinical Trial for StrepSure® GBS Rapid Sensor aimed at Point-of-Care Diagnostics for Expectant Mothers

By API User

21 October 2025 – Melbourne, Australia | Nexsen Limited (ASX:NXN), a nano-biotechnology company pioneering next-generation technology in point-of-care diagnostics, has announced the commencement of a pivotal clinical trial for its GBS Rapid Sensor, which is going to be marketed under the proprietary name StrepSure®.  The clinical trial marks a significant step in the validation of … Continued

AdvanCell’s 212Pb-ADVC001 demonstrates encouraging safety and compelling anti-tumor activity in Phase 1b in prostate cancer

By API User

Results from the TheraPb Phase 1b dose escalation presented at ESMO 2025 show a promising therapeutic index for 212Pb-ADVC001 in patients with metastatic castration-resistant prostate cancer (mCRPC) No dose-limiting toxicities and no treatment-related serious adverse events observed Xerostomia predominantly Grade 1 80% PSA50 response at doses ≥ 160 MBq 100% objective response rate (ORR) in … Continued

Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models

By API User

Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions. High-quality biological patient data, enriched and integrated for use by AI agents. PARIS, FRANCE, GB / ACCESS Newswire / October 16, 2025 / Owkin today announces the launch of K Pro, its co-pilot bringing advanced agentic AI to biomedical research … Continued

AdvanCell appoints experienced biotech and pharma leader, Andrew Kay, as Chair of the Board of Directors

By API User

Kay was instrumental in driving the successful development and commercialization ofXofigo®, the first and only approved alpha therapy to date SYDNEY, Australia – October 16, 2025 – AdvanCell, a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Andrew Kay as Director and Chair-elect of its Board of Directors, … Continued

OncoSil Medical (ASX:OSL) First OncoSil(TM) treatment in Germany

By API User

Pancreatic cancer treatment device company OncoSil Medical Limited (ASX:OSL) is pleased to announce the first patient treatment in Germany using the OncoSil™ device. The successful treatment was performed on 15 October 2025 at Universitätsklinikum Augsburg, a leading university hospital renowned for its excellence in oncology. This important milestone marks the commencement of OncoSil’s commercial activities in Germany, the … Continued